Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Other companies in Aprea Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), NKGen Biotech (NASDAQ:NKGN), HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM) and Coeptis Therapeutics (NASDAQ:COEP).
Aprea Therapeutics has a consensus price target of $10.60.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $3.65 last updated January 15, 2025 at 5:17 PM EST.
There are no upcoming dividends for Aprea Therapeutics.
Aprea Therapeutics’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
There is no upcoming split for Aprea Therapeutics.
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.